Cargando…

Identification of a Rare 3 bp BRAF Gene Deletion in a Thyroid Nodule by Mutant Enrichment with 3'-Modified Oligonucleotides Polymerase Chain Reaction

Papillary thyroid carcinoma (PTC) is the most common malignant thyroid tumor, and 36-69% of PTC cases are caused by mutations in the BRAF gene. The substitution of a valine for a glutamic acid (V600E) comprises up to 95-100% of BRAF mutations; therefore, most diagnostic methods, including allele-spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Mi-Ae, Lee, Seung-Tae, Oh, Young Lyun, Kim, Sun Wook, Chung, Jae Hoon, Ki, Chang-Seok, Kim, Jong-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339308/ https://www.ncbi.nlm.nih.gov/pubmed/22563563 http://dx.doi.org/10.3343/alm.2012.32.3.238

Ejemplares similares

Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules
por: Rosvall, Brandon R., et al.
Publicado: (2021)

Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of BRAF-Prevalent Population
por: Cho, Yoon Young, et al.
Publicado: (2020)

Evaluation of the Anyplex BRAF V600E Real-Time Detection Assay Using Dual-Priming Oligonucleotide Technology in Fine-Needle Aspirates of Thyroid Nodules
por: Choi, Rihwa, et al.
Publicado: (2015)

An Economic Modeling Study of Helicobacter pylori Eradication: Comparison of Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction and Empirical Treatment
por: Gweon, Tae-Geun, et al.
Publicado: (2018)

Quantification of Antisense Oligonucleotides by Splint Ligation and Quantitative Polymerase Chain Reaction
por: Shin, Minwook, et al.
Publicado: (2022)

Novel 4-bp Intronic Deletion (c.1560+3_1560+6del) in LEMD3 in a Korean Patient With Osteopoikilosis
por: Yoo, In Young, et al.
Publicado: (2017)

Effective Eradication Regimen and Duration According to the Clarithromycin Susceptibility of Helicobacter pylori Determined Using Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction
por: Na, Soo-Young, et al.
Publicado: (2023)

Peptide nucleic acid clamp polymerase chain reaction reveals a deletion mutation of the BRAF gene in papillary thyroid carcinoma: A case report
por: LEE, YONG-WHA
Publicado: (2013)

Dabrafenib for treatment of BRAF-mutant melanoma
por: Kainthla, Radhika, et al.
Publicado: (2013)

BRAF L485–P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
por: Zhang, Simeng, et al.
Publicado: (2023)

BRAF-mutant hematopoietic malignancies
por: Abdel-Wahab, Omar, et al.
Publicado: (2014)

Universal virus detection by degenerate-oligonucleotide primed polymerase chain reaction of purified viral nucleic acids
por: Nanda, Santosh, et al.
Publicado: (2008)

Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
por: Kim, Jae-Hyeon, et al.
Publicado: (2017)

Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules
por: Kim, Da Som, et al.
Publicado: (2018)

Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors
por: Jaiswal, Bijay S., et al.
Publicado: (2009)

3′ Tth Endonuclease Cleavage Polymerase Chain Reaction (3TEC-PCR) Technology for Single-Base-Specific Multiplex Pathogen Detection using a Two-Oligonucleotide System
por: Higgins, Owen, et al.
Publicado: (2021)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma
por: Di Stefano, Anna Luisa, et al.
Publicado: (2020)

Streptococcus pneumoniae Type Determination by Multiplex Polymerase Chain Reaction
por: Yun, Ki Wook, et al.
Publicado: (2011)

Inhibitors of pan-PI3K Signaling Synergize with BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
por: Sweetlove, Melanie, et al.
Publicado: (2015)

Targeting mutant BRAF in colorectal cancer
por: Carroll, David, et al.
Publicado: (2013)

Optimizing the treatment of BRAF mutant melanoma
por: Settleman, Jeff
Publicado: (2014)

Development of a Two Triplex Real-Time Polymerase Chain Reaction for Rapid Detection of Six Carbapenemase Genes in Enterobacteriaceae
por: Choi, Ji Ae, et al.
Publicado: (2020)

A novel 1-bp deletion in PITX3 causing congenital posterior polar cataract
por: Berry, Vanita, et al.
Publicado: (2011)

Reevaluation of the South Asian MYBPC3(Δ25bp) Intronic Deletion in Hypertrophic Cardiomyopathy
por: Harper, Andrew R., et al.
Publicado: (2020)

Primer fabrication using polymerase mediated oligonucleotide synthesis
por: Cairns, Murray J, et al.
Publicado: (2009)

Acquired resistance to BRAF inhibition in BRAF(V600E) mutant gliomas
por: Yao, Tsun-Wen, et al.
Publicado: (2016)

Biomechanical parameters of the BP-enriched bone cement
por: Matuszewski, Łukasz, et al.
Publicado: (2013)

Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons
por: Hauser, Stefan, et al.
Publicado: (2021)

Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays
por: Chung, Ki-Wook, et al.
Publicado: (2012)

Detection of genomic deletions in rice using oligonucleotide microarrays
por: Bruce, Myron, et al.
Publicado: (2009)

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation
por: Byeon, Hyung Kwon, et al.
Publicado: (2016)

Correlation of Sperm Mitochondrial DNA 7345 bp and 7599 bp Deletions with Asthenozoospermia in Jordanian Population
por: Zoubi, Mazhar Salim Al, et al.
Publicado: (2021)

Analytic and clinical validity of thyroid nodule mutational profiling using droplet digital polymerase chain reaction
por: Biron, Vincent L., et al.
Publicado: (2018)

Variations of BRAF mutant allele percentage in melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2015)

Novel combination therapies for BRAF-mutant melanoma
por: McArthur, Grant A
Publicado: (2015)

Agents to treat BRAF-mutant lung cancer
por: Alvarez, Jean G Bustamante, et al.
Publicado: (2019)

Current Advances in the Treatment of BRAF-Mutant Melanoma
por: Patel, Hima, et al.
Publicado: (2020)

Mutant-selective degradation by BRAF-targeting PROTACs
por: Alabi, Shanique, et al.
Publicado: (2021)

Intermittent BRAF Inhibition Can Achieve Prolonged Disease Control in BRAF Mutant Melanoma
por: Jain, Tania, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gtebpmev7bfnh1rlmn0s1en07s